API Market: Trends in Drug Master Filings Across the U.S., Europe, Japan and China in 2025

QYOBO’s intelligence platform is the world’s first to map the entire pharmaceutical manufacturing universe at site level. Drawing on QYOBO’s visibility into over 15,000 manufacturing sites worldwide, combined with Drug Master Filings (DMF) data from EDQM, NMPA, PMDA, and USFDA, this is the first analysis to compare API submissions across the U.S., Europe, Japan, and China.